首页> 外文期刊>Infection and immunity >Genetic Immunization of BALB/c mice with a Plasmid Bearing the Gene Coding for a Hybrid Merozoite Surface Protein 1-Hepatitis B Virus Surface Protein Fusion Protects Mice against Lethal Plasmodium chabaudi chabaudi PC1 Infection
【24h】

Genetic Immunization of BALB/c mice with a Plasmid Bearing the Gene Coding for a Hybrid Merozoite Surface Protein 1-Hepatitis B Virus Surface Protein Fusion Protects Mice against Lethal Plasmodium chabaudi chabaudi PC1 Infection

机译:BALB / c小鼠的遗传免疫,其质粒带有杂合子表面蛋白1-乙型肝炎病毒表面蛋白融合基因编码,可保护小鼠免受致死性疟原虫chabaudi chabaudi PC1感染

获取原文
       

摘要

The genetic immunization of rodents with a plasmid coding for aPlasmodium chabaudi merozoite surface protein 1 (C terminus)-hepatitis B virus surface fusion protein (pPcMSP119-HBs) provided protection of mice against subsequent lethal challenge with P. chabaudi chabaudiPC1-infected red blood cells. The percentage of survivor mice was higher in DNA-immunized mice than in animals immunized with a recombinant rPcMSP119– glutathioneS-transferase fusion protein administered in Freund adjuvant. In all mice immunized with the pPcMSP119-HBs, a Th1-specific response, including the production of anti-MSP119-specific immunoglobulins predominantly of the immunoglobulin G2a subtype and reacting almost exclusively against discontinuous epitopes, was elicited. The coinjection of Th1-type cytokine-expressing plasmids (gamma interferon, interleukin-2, and granulocyte-macrophage colony-stimulating factor) mostly abolished protection and boosting of MSP119-specific antibodies. The inclusion of a lymph node-targeting signal did not significantly increase protection. These data provide further evidence that MSP119-HBs DNA constructs might be useful as components of a genetic vaccine against the asexual blood stages ofPlasmodium.
机译:用编码 chabaudi 裂殖子表面蛋白1(C末端)-乙型肝炎病毒表面融合蛋白(pPcMSP1 19 -HBs)的质粒对啮齿类动物进行遗传免疫小鼠抵抗随后的 P致死性攻击。 chabaudi chabaudi PC1感染的红细胞。 DNA免疫小鼠中存活小鼠的比例高于弗氏佐剂中重组rPcMSP1 19 -谷胱甘肽 S -转移酶融合蛋白免疫的动物。在用pPcMSP1 19 -HBs免疫的所有小鼠中,Th1特异性应答,包括主要是免疫球蛋白G2a亚型的抗MSP1 19 特异性免疫球蛋白的产生和反应引发了几乎专门针对不连续表位的抗原。 Th1型细胞因子表达质粒(γ干扰素,白介素2和粒细胞巨噬细胞集落刺激因子)的共同注射在很大程度上消除了对MSP1 19 特异性抗体的保护和增强作用。包含淋巴结靶向信号并未显着增加保护作用。这些数据提供了进一步的证据,证明MSP1 19 -HBs DNA构建体可用作针对 Plasmodium 的无性血液阶段的基因疫苗的组成部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号